Home › Compare › AGIN vs JNJ

AGIN vs JNJ: Dividend Comparison 2026

AGIN yields 83333.33% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGIN wins by $7.827354174349132e+25M in total portfolio value
10 years
AGIN
AGIN
● Live price
83333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.827354174349132e+25M
Annual income
$78,089,205,798,879,010,000,000,000,000,000.00
Full AGIN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AGIN vs JNJ

📍 AGIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGINJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGIN + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AGIN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGIN
Annual income on $10K today (after 15% tax)
$7,083,333.33/yr
After 10yr DRIP, annual income (after tax)
$66,375,824,929,047,160,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, AGIN beats the other by $66,375,824,929,047,160,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGIN + JNJ for your $10,000?

AGIN: 50%JNJ: 50%
100% JNJ50/50100% AGIN
Portfolio after 10yr
$3.913677087174566e+25M
Annual income
$39,044,602,899,439,506,000,000,000,000,000.00/yr
Blended yield
99.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AGIN
No analyst data
Altman Z
-59.5
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGIN buys
0
JNJ buys
0
No recent congressional trades found for AGIN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGINJNJ
Forward yield83333.33% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$7.827354174349132e+25M$20.0K ✓
Annual income after 10y$78,089,205,798,879,010,000,000,000,000,000.00 ✓$827.78
Total dividends collected$7.826145752529585e+25M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AGIN vs JNJ ($10,000, DRIP)

YearAGIN PortfolioAGIN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$8,344,033$8,333,333.33$10,676$355.77+$8.33M → AGIN
2$6,507,396,444$6,498,468,328.14$11,407$389.39+$6507.39M → AGIN
3$4,743,472,976,069$4,736,510,061,874.32$12,198$426.53+$4743472.96M → AGIN
4$3,231,814,615,629,740$3,226,739,099,545,346.00$13,056$467.62+$3231814615.62M → AGIN
5$2,058,071,288,713,008,000$2,054,613,247,074,284,500.00$13,987$513.12+$2058071288712.99M → AGIN
6$1,225,015,790,649,354,000,000$1,222,813,654,370,431,000,000.00$14,998$563.56+$1225015790649354.00M → AGIN
7$681,543,888,689,022,700,000,000$680,233,121,793,028,000,000,000.00$16,098$619.52+$681543888689022720.00M → AGIN
8$354,421,985,930,988,300,000,000,000$353,692,733,970,091,100,000,000,000.00$17,295$681.69+$354421985930988290048.00M → AGIN
9$172,276,583,749,827,040,000,000,000,000$171,897,352,224,880,900,000,000,000,000.00$18,599$750.82+$1.7227658374982704e+23M → AGIN
10$78,273,541,743,491,320,000,000,000,000,000$78,089,205,798,879,010,000,000,000,000,000.00$20,022$827.78+$7.827354174349132e+25M → AGIN

AGIN vs JNJ: Complete Analysis 2026

AGIN — Stock

American Graphite Technologies, Inc., an exploration stage company, engages in the exploration and development of graphite and graphene mineral properties. It holds a 100% interest in the Lac Rouge graphite property, which consists of 84 mineral claims covering an area of 4,982 hectares of land located near the town of Mont-Laurier in southern Quebec. The company was formerly known as Green & Quality Home Life, Inc. and changed its name to American Graphite Technologies Inc. in July 2012. American Graphite Technologies Inc. was founded in 2010 and is based in Las Vegas, Nevada.

Full AGIN Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AGIN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGIN vs SCHDAGIN vs JEPIAGIN vs OAGIN vs KOAGIN vs MAINAGIN vs ABBVAGIN vs MRKAGIN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.